Ligand Pharmaceuticals

+$3.49 (+4.20%) As of 7:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV.

CEO
John L. Higgins
Employees
154
Headquarters
Emeryville, California
Founded
1987

LGND Key Statistics

Market cap
1.46B
Price-Earnings ratio
60.35
Dividend yield
—
Average volume
140.25K
High today
$87.26
Low today
$83.88
Open price
$83.88
Volume
86.02K
52 Week high
$169.98
52 Week low
$77.80

LGND Earnings

$0.00
$0.60
$1.20
$1.80
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure